1. Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium. Issue 3 (23rd February 2020) Authors: Iskierka-Jażdżewska, Elżbieta; Canzian, Federico; Stępień, Anna; Martino, Alessandro; Campa, Daniele; Stein, Angelica; Krawczyk-Kuliś, Małgorzata; Rybicka-Ramos, Malwina; Kyrcz-Krzemień, Sławomira; Butrym, Aleksandra; Mazur, Grzegorz; Jurczyszyn, Artur; Zawirska, Daria; Grząśko, Norbert; Tomczak,... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 3(2020) Page Start: 699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗